Opera Trading Capital’s Colgate-Palmolive CL Stock Holding History

Opera Trading Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,338	Closed	-$247K	–	156
2017 Q2	$247K	Buy	+3,338	New	+$248K	0.04%	108

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Opera Trading Capital's CL Position: Q3 2017 in Review

Opera Trading Capital sold out of Colgate-Palmolive (CL) in Q3 2017, closing a stake of 3,338 shares — an estimated $247K sold.

Opera Trading Capital first reported a position in CL in Q2 2017 and held it in 1 quarter. The position peaked at $247K in Q2 2017. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

Opera Trading Capital reported no remaining Colgate-Palmolive position as of Q3 2017 after selling out during the quarter.
Opera Trading Capital sold 3,338 Colgate-Palmolive shares in Q3 2017, an estimated $247K.
Opera Trading Capital first reported a position in Colgate-Palmolive in Q2 2017 and held it in 1 quarter.
Opera Trading Capital's Colgate-Palmolive position peaked at $247K in Q2 2017.
1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on Opera Trading Capital's 13F filing for Q3 2017, filed 6 Nov 2017.